The on-demand video of the webinar „CDK4/6 inhibition in early breast cancer – Recent data and controversies?“ is now available!
22.11.2023The virtual continuing education event “CDK4/6 inhibition in early breast cancer – Recent data and controversies?” took place on Wednesday, November 8th, 2023 (05:30 – 07:00 pm, CET). A total of 104 participants from 13 countries participated in the webinar.
We would like to thank our sponsors Lilly and Novartis and all speakers and panelists for their informative presentations and their engaging input in the discussion.
For those who have missed the webinar, the on-demand video of the virtual meeting is now available in the → ABCSG Members Area.
Mehr Beiträge zum Thema:
CDK4/6 Inhibitors
Teilen auf